Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Endosomal TLRs play an important role in innate immune response as well as in autoimmune processes. In the therapy of systemic lupus erythematosus, antimalarial drugs chloroquine, hydroxychloroquine, and quinacrine have been used for a long time. Their suppression of endosomal TLR activation has been attributed to the inhibition of endosomal acidification, which is a prerequisite for the activation of these receptors. We discovered that chloroquine inhibits only activation of endosomal TLRs by nucleic acids, whereas it augments activation of TLR8 by a small synthetic compound, R848. We detected direct binding of antimalarials to nucleic acids by spectroscopic experiments and determined their cellular colocalization. Further analysis revealed that other nucleic acid-binding compounds, such as propidium iodide, also inhibited activation of endosomal TLRs and colocalized with nucleic acids to endosomes. We found that imidazoquinolines, which are TLR7/8 agonists, inhibit TLR9 and TLR3 even in the absence of TLR7 or TLR8, and their mechanism of inhibition is similar to the antimalarials. In contrast to bafilomycin, none of the tested antimalarials and imidazoquinolines inhibited endosomal proteolysis or increased the endosomal pH, confirming that inhibition of pH acidification is not the underlying cause of inhibition. We conclude that the direct binding of inhibitors to nucleic acids mask their TLR-binding epitope and may explain the efficiency of those compounds in the treatment…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In phagocytic cells, the deacidification of endosomes using pharmacological inhibitors like chloroquine has been shown to reduce endosomal toll-like receptor (TLR) response (de Bouteiller et al., 2005; Fox, 2019; Kuznik et al., 2011; Wozniacka et al., 2006; Yang et al., 2016)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Kuznik et al., 2011
In the citing paper
“Hydroxychloroquine (HCQ) is an approved anti-malaria drug, and accumulation of hydroxychloroquine inhibits the binding ability of TLR9 to DNA and subsequent immune activation (77).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [77]
Citations
Cites
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,522
ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,032
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., & Tashiro, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47429-2 · Cited by 1,328
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8
Gorden, K. B., Gorski, K. S., Gibson, S. J., Kedl, R. M., Kieper, W. C., Qiu, X., Tomai, M. A., Alkan, S. S., & Vasilakos, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1259 · Cited by 683
Häcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 653
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G.-P., Chapman, H. A., & Barton, G. M. (2008) · Nature · doi:10.1038/nature07405 · Cited by 617
Research works printed but not linked: 2
- Ahmad-Nejad, 2002, Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments, Eur. J. Immunol., 32, 1958, 10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · DOI · Paper page
- Peacocke, 1973, Acridines, 723
Cited by
Items 401–500 of 627
Chen, P., & Lv, J. (2024) · Nephrology · doi:10.1111/nep.14369 · Cited by 9
Godbole, S., Solomon, J. L., Johnson, M., Srivastava, A., Carsons, S. E., Belilos, E., Leon, J. D., & Reiss, A. B. (2024) · Biomedicines · doi:10.3390/biomedicines12071608 · Cited by 11
Milazzo, R., Ligato, E., Laoreti, A., Ferri, G., Basili, L., Serati, L., Brucato, A. L., & Cetin, I. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.01.031 · Cited by 9
Tang, C., Si, F., Yao, Y., Lv, J., Shi, S., Chen, Y., Liu, L., & Zhang, H. (2021) · Nephrology · doi:10.1111/nep.13991 · Cited by 9
Martínez-García, E. A., Zavala-Cerna, M. G., Lujano-Benítez, A. V., Sánchez‐Hernández, P. E., Martín-Márquez, B. T., Sandoval-García, F., & Mercado, M. V.-D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01497 · Cited by 9
Al‐Bari, M. A. A. (2020) · Current Drug Targets · doi:10.2174/1389450121666200617133142 · Cited by 10
Gašperšič, J., & Dolžan, V. (2022) · Biology · doi:10.3390/biology11020178 · Cited by 9
Venuturupalli, S., Gudsoorkar, V. S., & Wallace, D. J. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111616 · Cited by 9
Hydroxychloroquine and lupus flare: a good drug, but we need to do better
Crow, M. K., & Kirou, K. A. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221590 · Cited by 10
Antimalarial drugs: discovery, mechanism of action, and drug resistance
Yadav, G. P., Arukha, A. P., Kothapalli, Y., & Singh, U. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95328-3.00008-8 · Cited by 12
Pan, X., Li, B., Kuang, M., Liu, X. B., Cen, Y., Qin, R., Ding, G., Zheng, J., & Zhou, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020242 · Cited by 8
Emergence of novel coronavirus and progress toward treatment and vaccine
Khan, M. M., Noor, A., Madni, A., & Shafiq, M. M. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2116 · Cited by 9
Renner, P., Crone, M., Kornas, M., Pioli, K. T., & Pioli, P. D. (2022) · Antibody Therapeutics · doi:10.1093/abt/tbac013 · Cited by 9
Cutaneous purpura of Sjögren syndrome successfully treated with hydroxychloroquine
Hile, G. A., Lowe, L., & Kahlenberg, J. M. (2017) · JAAD Case Reports · doi:10.1016/j.jdcr.2017.04.011 · Cited by 8
Hayakawa, K., Fujishiro, M., Yoshida, Y., Kataoka, Y., Sakuma, S., Nishi, T., Ikeda, K., Morimoto, S., Takamori, K., & Sekigawa, I. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac012 · Cited by 9
Pietto, M. C. B., Glembotsky, A. C., Lev, P. R., Oyarzún, C. P. M., Luca, G. D., Gómez, G. N., Collado, M. V., Charó, N. L., Cellucci, A. S., Heller, P. G., et al. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152782 · Cited by 8
Volkov, M. (2016) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2016-78-85 · Cited by 9
Puyo, C. A., Earhart, A., Staten, N. R., Huang, Y., Desai, A. C., Lai, H. H., & Venkatesh, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-24818-w · Cited by 8
Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia
Stremmel, C., Kellnar, A., Maßberg, S., & Kääb, S. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420935740 · Cited by 8
Kwatra, S. G. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.04.068 · Cited by 8
Hydroxychloroquine treatment for Alopecia Universalis: Report of six cases
Akdoğan, N., & Evans, S. E. (2020) · Australasian Journal of Dermatology · doi:10.1111/ajd.13391 · Cited by 7
New Insights Into Systemic Lupus Erythematosus Therapies
Wang, D. H., & Wallace, D. J. (2020) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001603 · Cited by 9
Intracellular TLRs of Mast Cells in Innate and Acquired Immunity
Ogawa, Y., Kinoshita, M., Kawamura, T., & Shimada, S. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_540 · Cited by 7
Immunosuppression in Rheumatologic and Auto-immune Disease
Jayatilleke, A. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_551 · Cited by 7
Kast, R. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015474 · Cited by 7
Paredes, D., Martín‐Iglesias, D., & Ruiz‐Irastorza, G. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2294938 · Cited by 7
Xing, N., Qiao, T., Zhuang, X., Yuan, S., Zhang, Q., & Xu, G. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s84467 · Cited by 7
A new trick for an ancient drug: quinine dissociates antiphospholipid immune complexes
Bezati, E., Wu, X.-X., Quinn, A., Taatjes, D. J., & Rand, J. H. (2014) · Lupus · doi:10.1177/0961203314547792 · Cited by 7
Park, S. K., Jin, S. Y., Yeon, S. H., Lee, S. B., Xu, J., Yoon, Y. H., Rha, K., & Kim, Y. M. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22155 · Cited by 8
The effect of hydroxychloroquine on platelet activation in model experiments
Schreiber, K. I., Sciascia, S., Wehrmann, F., Weiß, C., Leipe, J., Krämer, B. K., & Stach, K. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02325-y · Cited by 7
Antimalarials in Lupus Nephritis: How Strong Is the Evidence?
Caravaca‐Fontán, F., Yandián, F., Zand, L., Sethi, S. M., & Fervenza, F. C. (2024) · Kidney360 · doi:10.34067/kid.0000000626 · Cited by 6
Chen, Q., Wang, Z., Lv, J., Liu, L., Li, H., Sun, W., Huo, Y., Guo, Y., Shen, C., Li, S., et al. (2022) · Trials · doi:10.1186/s13063-022-06336-3 · Cited by 6
Whole blood hydroxychloroquine: Does genetic polymorphism of cytochrome P450 enzymes have a role?
Jatta, N., Stanslas, J., Yong, A. C. H., Ho, W. C., Kammal, W. S. L. W. A., Chua, E. W., & How, K. N. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01142-w · Cited by 6
Yang, H. Y., Fung, S., Bao, A., Li, Q., & Turvey, S. E. (2017) · Journal of Visualized Experiments · doi:10.3791/56075 · Cited by 6
Minnaert, A., Devoldere, J., Peynshaert, K., Vercruysse, L., Smedt, S. C. D., & Remaut, K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010074 · Cited by 6
Allen, M. E., Golding, A., Rus, V., Karabin, N. B., Li, S., Lescott, C. J., Bobbala, S. K. R., Scott, E. A., & Szeto, G. L. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01047 · Cited by 6
Target in Sight: A Comprehensive Review of Hydroxychloroquine-Induced Bull’s Eye Maculopathy
Snow, Z. E., Seely, K. R., Barrett, S. C., Pecha, J. D., & Goldhardt, R. (2024) · Current Ophthalmology Reports · doi:10.1007/s40135-024-00321-6 · Cited by 6
Hitti, E., Muazzen, Z., Moghrabi, W. N., Al‐Yahya, S., & Khabar, K. S. A. (2024) · Immunology · doi:10.1111/imm.13835 · Cited by 6
Granulocytes: Neutrophils, Basophils, Eosinophils
Bosch, X., & Ramos‐Casals, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00013-0 · Cited by 6
Bacterial DNA Protects Monocytic Cells against HIV-Vpr–Induced Mitochondrial Membrane Depolarization
Saxena, M., Busca, A., Holčík, M., & Kumar, A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1402379 · Cited by 5
Teofilović, N. K., Bihi, M., Stojković, M. R., Tumir, L., Ester, K., Kralj, M., Majhen, D., Oršolić, N., Lepur, A., Vrbanec, D., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.02.048 · Cited by 5
Bosch, X., & Ramos‐Casals, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00014-9 · Cited by 5
Proskurina, A. S., Spaselnikova, A. V., Ritter, G. S., Долгова, Е. В., Potter, E. A., Romanenko, M. V., Sv, N., Efremov, Y. R., Taranov, O. S., Анатольевич, В. Н., et al. (2019) · European Cytokine Network · doi:10.1684/ecn.2019.0427 · Cited by 5
Clinical, pharmacokinetic and technological aspects of the hydroxychloroquine sulfate
Ferraz, L. R. D. M., Santos, F. L. A., Ferreira, P. D. A., Maia, R. T. L., Rosa, T. A., Rolim, L. A., & Neto, P. J. R. (2014) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.9790/3013-04011053064 · Cited by 6
Hydroxychloroquine’s diverse targets: a new frontier in precision medicine
Du, B., Li, L., Li, J., Liu, Y., & Wang, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1655573 · Cited by 4
Hua, Z., Chen, B., Gong, B., Lin, M., Ma, Y., & Li, Z. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14664 · Cited by 4
Rao, R., & Singh, J. (2025) · Journal of Biosciences · doi:10.1007/s12038-025-00501-x · Cited by 4
Zothantluanga, J. H., Tayeng, D., Abdalla, M., Rajkhowa, S., Eltayb, W. A., & Chetia, D. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120150 · Cited by 4
FcγRIIIa Signaling Modulates Endosomal TLR Responses in Human CD4+ T Cells
Chauhan, A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601954 · Cited by 4
A Case of Hydroxychloroquine Induced Hypoglycaemia in a Non-Diabetic Patient
Richard, D.-H., & Doherty, T. (2018) · Journal of Rheumatic Diseases and Treatment · doi:10.23937/2469-5726/1510066 · Cited by 4
How Advanced are Nanocarriers for Effective Subretinal Injection?
Guan, J.-X., Wang, Y.-L., & Wang, J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s479327 · Cited by 5
Management of Cutaneous Lupus Erythematosus
Chong, B. F., & Werth, V. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00058-x · Cited by 4
Role of Toll-Like Receptor (TLR)-Signaling in Cancer Progression and Treatment
Prasad, S. B., & Kumar, R. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.94423 · Cited by 6
Viryasova, G. M., Golenkina, E. A., Hianik, T., Soshnikova, N. V., Dolinnaya, N. G., Gaponova, T. V., Romanova, Y. M., & Sud’ina, G. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052671 · Cited by 5
Mécanismes physiopathologiques du lupus systémique
Mathian, A., Dorgham, K., Gorochov, G., & Amoura, Z. (2021) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2021.10.006 · Cited by 6
Hydroxychloroquine suppresses anti-GBM nephritis via inhibition of JNK/p38 MAPK signaling
Torigoe, M., Obata, Y., Inoue, H., Torigoe, K., Kinoshita, A., Koji, T., Mukae, H., & Nishino, T. (2022) · Clinical and Experimental Nephrology · doi:10.1007/s10157-022-02285-y · Cited by 4
Novel quinoline substituted autophagy inhibitors attenuate Zika virus replication in ocular cells
Singh, S., Ahmad, F., Aruri, H., Das, S., Parajuli, P., Gavande, N. S., Singh, P. K., & Kumar, A. (2024) · Virus Research · doi:10.1016/j.virusres.2024.199419 · Cited by 4
Günther, C., & Beissert, S. (2015) · Der Hautarzt · doi:10.1007/s00105-015-3644-7 · Cited by 4
Non‐adherence to hydroxychloroquine in systemic lupus erythematosus: The elephant in the clinic room
Mok, C. C. (2024) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.15188 · Cited by 3
Mbogo, G. W., Kroner, P., Walsh, R., Newchurch, J., & Bleackley, M. R. (2025) · Scientific Reports · doi:10.1038/s41598-025-04573-5 · Cited by 3
Chiu, T., Huang, H., Liew, H., Chang, H., Wu, H.-R., & Wang, M.-J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157099 · Cited by 3
Kalyniuk, K., Fetter, T., Grützbach, M., Guel, T., Novak, N., & Wenzel, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1648001 · Cited by 3
Werth, V. P., Rönnblom, L., Wenzel, J., Moseley, M. K., Rohrbach, J., Reynolds, T. L., Barbey, C., Grogan, J. L., & Colonna, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1807771 · Cited by 3
Cytokines in cutaneous lupus erythematosus
Wittmann, M., & Goodfield, M. J. D. (2011) · Expert Review of Dermatology · doi:10.1586/edm.11.39 · Cited by 3
Elucidating the mechanisms and efficacy of antimalarial drugs in systemic lupus erythematosus
Paredes, D., Martín‐Iglesias, D., Amo, L., & Ruiz‐Irastorza, G. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2412252 · Cited by 3
Garellick, V., Gul, N., Horrieh, P., Mustafa, D., Patel, A. A. H., Dankis, M., Alvarez, S., Berndtson, J., Mahdavi, S., Schwarz, M., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103988 · Cited by 5
Covid-19 Therapy: What Have We Learned In 8 Months?
Adamczyk-Popławska, M., & Kwiatek, A. (2020) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2020.59.3.15 · Cited by 3
Overbury, R. S., Stoddard, G. J., Pupaibool, J., Hansen, C. B., & Lebiedz‐Odrobina, D. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06954-8 · Cited by 3
Takei, H., Takanashi, S., Otomo, K., Hanaoka, H., Kikuchi, J., Yamaoka, K., Yoshimoto, K., Abe, T., Takeuchi, T., & Kaneko, Y. (2022) · Modern Rheumatology · doi:10.1093/mr/roac153 · Cited by 3
Boudjeniba, C., Soret, P., Trutschel, D., Hamon, A., Baloche, V. M. D., Chassagnol, B., Desvaux, E., Bichat, A., Aussy, A., Moingeon, P. E., et al. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110241 · Cited by 3
Dong, C., Chen, B. S., Wu, C. H., Chiu, Y., Liao, P., & Perng, W. (2024) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.15286 · Cited by 3
Inhibitory effect of hydroxychloroquine on glucocorticoid‐induced osteoporosis in lupus therapy
Qiu, W., Han, X., Yu, T., Jiang, L., Wang, X. J., Feng, R., Duan, X., Teng, Y., Yin, H., Bokarewa, M. I., et al. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.70010 · Cited by 3
Shi, Y., Wang, Y., Li, N., Shao, Q., Jiang, C., Yang, T., & Liu, J. (2024) · Kidney Diseases · doi:10.1159/000543131 · Cited by 3
Hydroxychloroquine Prevents Antiphospholipid Antibody-Induced Inhibition Of Trophoblast Migration
Albert, C. R. (2015) · Cited by 4
Tselios, K., & Urowitz, M. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803267-1.00010-7 · Cited by 3
Antimalarial phytochemicals as inhibitors against COVID-19 ACE2 receptor: Computational screening
Benslama, O., Mansouri, N., & Arhab, R. (2021) · Notulae Scientia Biologicae · doi:10.15835/nsb13210835 · Cited by 3
Siddique, F., Patel, D. P., & Roberts, W. N. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_161 · Cited by 3
Antimalarials in rheumatology: Expanding therapeutic armamentarium
Thabah, M. M., & Ravindran, V. K. (2015) · Indian Journal of Rheumatology · doi:10.1016/j.injr.2015.04.001 · Cited by 3
Hydroxychloroquine - safety in pregnancy
VĂRȘA, R. G., Gică, N., Botezatu, R., Peltecu, G. C., & Panaitescu, A. M. (2022) · Romanian Journal of Rheumatology · doi:10.37897/rjr.2022.1.1 · Cited by 2
Target Autophagy as a Novel Therapeutic Strategy in Autoimmune Diseases
Wilhelm, M., & Muller, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-30079-5_13 · Cited by 2
Kang, S., Monteith, A. J., Arbeeva, L. S., Grier, K., Beem, S. S., Trujillo, A., Bi, X., Sun, K., Sadun, R. E., Maheswaranathan, M., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.191767 · Cited by 2
Strategies for Evading Cellular Immunity Against Recombinant AAV Vectors in Gene Therapy
Wang, Z., Wu, X., Fu, D.-Y., Li, X., Liu, D., Liu, S., Zhao, Q., & Wang, H. (2026) · Current Medical Science · doi:10.1007/s11596-026-00178-9 · Cited by 2
TenBarge, E. G., Wise, A. D., Hetzel, M. L., Hoover, H. A., Esfandiari, H., Holder, B. E., Belevska, E., Mennen, E. C., McDaniel, S. R., Vaccaro, N. M., et al. (2026) · Cell Press Blue · doi:10.1016/j.cpblue.2026.100080 · Cited by 2
Kłosowicz, A., Pastuszczak, M., Dyduch, G., Englert, K., Łukasik, A., & Wojas‐Pelc, A. (2020) · Dermatologic Therapy · doi:10.1111/dth.14509 · Cited by 2
Luo, W., Ige, O. O., Beacon, T. H., Su, R., Huang, S., Davie, J., & Lakowski, T. M. (2020) · Genome · doi:10.1139/gen-2020-0130 · Cited by 2
Review the Use of Antivirus for COVID-19 Treatment
Prayitno, L., Mawuntu, J. R., Herna, & Angkasawati, T. J. (2020) · Journal of Health Management · doi:10.1177/0972063420983113 · Cited by 2
OKANO, A., Tanaka, S., YAMADA, K., Hashimoto, N., & Watanabe, J. (2024) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2023-073 · Cited by 2
Ba, R., Liu, B., Feng, Z., Wang, G., Niu, S., Wang, Y., Jiao, X., Wu, C., Yu, F., Zhou, G., et al. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04517-0 · Cited by 2
Li, X.-Y., Pan, L., Deng, Y.-W., Chen, J., Tian, Z., Tang, G., Ge, S., & Wang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1551311 · Cited by 2
Environmental Exposures of Concern for Rheumatologists
Khosravi‐Hafshejani, T., Ali, H., Gomes, L. L. A., & Werth, V. P. (2025) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2025.09.006 · Cited by 2
Hurtado, P. R., Hurtado-Perez, E., Luo, C., Bednarz, J., Hissaria, P., & Peh, C. A. (2019) · Lupus · doi:10.1177/0961203319897810 · Cited by 2
Therapeutic modalities in systemic lupus erythematosus
Tyagi, N., & Lahita, R. G. (2013) · Saudi Medical Journal · doi:10.15537/1658-3175.5812 · Cited by 2
Pharmacology in the musculoskeletal system
Williams, A. S., & Goodfellow, R. (2013) · Nurse Prescribing · doi:10.12968/npre.2013.11.10.499 · Cited by 2
Db, K. (2017) · Practical oncology · doi:10.31917/1801139 · Cited by 5
Hydroxychloroquine and the Prevention of Pregnancy Losses
Frishman, M., Radin, M., Cecchi, I., Sciascia, S., & Schreiber, K. I. (2019) · Current Opinion in Gynecology and Obstetrics · doi:10.18314/cogo.v2i1.1950 · Cited by 2
A review of potential pharmacological treatments of COVID-19: an evidence-based perspective
Kumar, V., Vardhan, G., Tiwari, K., & Dhamija, P. (2020) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20204507 · Cited by 2
Silva, L. M. T., Cortes, A., Rossi, B., Boll, L. F. C., Waclawovsky, G., Eibel, B., Gonçalves, S. C., Irigoyen, M. C., & Martinez, D. (2021) · Trials · doi:10.1186/s13063-021-05610-0 · Cited by 3
Chloroquine and Hydroxychloroquine in the Treatment of Dry Eye Disease
Prinz, J., Maffulli, N., Fuest, M., Walter, P., Hildebrand, F., & Migliorini, F. (2023) · Diseases · doi:10.3390/diseases11020085 · Cited by 2
Preliminary evidence that Merkel cells exert chemosensory functions in human epidermis
Piccini, I., Chéret, J., Tsutsumi, M., Sakaguchi, S., Ponce, L., Almeida, L., Funk, W., Kückelhaus, M., Kajiya, K., Paus, R., et al. (2023) · Experimental Dermatology · doi:10.1111/exd.14907 · Cited by 2
Siddique, F., Patel, D. P., & Roberts, W. N. (2015) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_161-6 · Cited by 2
Metadata
- Authors
- Kužnik, A., Benčina, M., Švajger, U., Jeras, M., Rozman, B., & Jerala, R.
- Affiliations
- National Institute of Chemistry (SI)
- Blood Transfusion Centre of Slovenia (SI)
- Ljubljana University Medical Centre (SI)
- University of Ljubljana (SI)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-04
- Volume
- 186
- Issue
- 8
- Pages
- 4794-4804
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2118400571
- Cited by
- 606
- References
- 40
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 43 · 2023: 30 · 2022: 42 · 2021: 69 · 2020: 89 · 2019: 38 · 2018: 39 · 2017: 38 · 2016: 41 · 2015: 43 · 2014: 32 · 2013: 22 · 2012: 28
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Repository of the University of Ljubljana (University of Ljubljana) (publishedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- antimalarial drugs, imidazoquinolines, chloroquine, hydroxychloroquine, quinacrine, TLR8, R848, nucleic acid binding, endosomal acidification, TLR9, TLR3, TLR7/8 agonist, systemic lupus erythematosus, autoimmune disease therapy, propidium iodide, bafilomycin
- MeSH terms
- Animals, Antimalarials, Binding, Competitive, Cell Line, Cells, Cultured, Chloroquine, Culture Media, Humans, Hydrogen-Ion Concentration, Imidazoles, Nucleic Acids, Quinacrine, Quinolines, Endosomes, Transfection, Cytokines, Serum, Toll-Like Receptors, Toll-Like Receptor 3, Toll-Like Receptor 7, Toll-Like Receptor 8, Toll-Like Receptor 9, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.